CD8 T Cell Response to Murine Cytomegalovirus
CD8 T Cell Response to Murine Cytomegalovirus
批准号:
8387894
负责人:
Ann B Hill
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-15 至 2016-07-31
关键词:
Adoptive TransferAgeAntigen PresentationAntigen-Presenting CellsAntigensAutomobile DrivingBiological AssayBone MarrowCD4 Positive T LymphocytesCD8B1 geneCancer VaccinesCell CountCell SeparationCellsChronicChronic DiseaseChronic PhaseClinical PathologyCompetenceCross PresentationCytomegalovirusCytomegalovirus InfectionsCytomegalovirus VaccinesDNA biosynthesisDendritic CellsDetectionDigestionDiseaseEconomic InflationEffector CellElderlyEngineeringEnvironmentFundingGene ExpressionGenomicsGoalsGrantHIVHuman VirusHybridomasITGAX geneImmuneImmune responseImmune systemIndividualInfectionInflammatoryKnowledgeLifeLocationLongevityMemoryMurid herpesvirus 1MusOrganPhenotypePlayPopulationProcessPropertyReportingResourcesRoleSpleenT cell responseT-LymphocyteTimeTissuesTransplant RecipientsVaccinesVascular DiseasesViralViral AntigensViral GenesViral GenomeVirusWorkbasecell typecytokineimmunosenescenceprogramsrecombinaseresponsevectorvector vaccine
中文摘要
描述(由申请人提供):巨细胞病毒(CMV)感染的特征是巨大的效应/记忆T细胞应答,终生维持在高水平-一种称为记忆膨胀的现象。我们已经报道,“膨胀记忆”细胞实际上是短寿命的效应细胞,不断从感染早期产生的真正的记忆细胞分化。真正的记忆细胞不容易从受感染宿主的脾脏转移到受感染的受体,我们认为它们存在于基质龛中。我们还表明,一个单周期的CMV在第一次进入人体时无法传播到它感染的细胞之外,这会驱动令人惊讶的强大记忆膨胀。这两个发现定义了我们在这个项目中试图解开的悖论:少量受感染的细胞如何呈递抗原以保持免疫系统持续激活而不被免疫根除?我们首先要问的是,关于病毒存在的信息是否通过病毒抗原的直接或交叉呈递传递给T细胞。这将通过产生表达Kb的病毒以限制抗原呈递至直接感染的细胞来实现。
接下来,我们将使用器官消化、细胞分选和生物测定的迭代过程来鉴定携带病毒基因组的细胞和将抗原呈递给T细胞的细胞。作为一种替代方法,我们将产生病毒,该病毒可用于感染cre小鼠,以将抗原表达限制在特定组织或细胞类型。最后,我们将描述潜伏感染者的特征,
细胞的免疫表型、病毒基因表达以及在与记忆性CD 8和CD 4 T细胞共过继转移后驱动记忆膨胀的充分性。了解驱动记忆膨胀的病毒程序将使我们能够智能地
工程化CMV载体作为疫苗以产生有效的免疫应答。它也将帮助我们了解CMV在某些慢性疾病中的作用,以及它与免疫衰老的假定联系。
公共卫生相关性:巨细胞病毒是一种普遍存在的人类病毒,可激发受感染宿主产生极大的免疫反应。这种巨大的免疫反应可能是有害的,有助于老年人的免疫衰老,或者当CMV用作疫苗载体时是有益的。目前尚不清楚为什么免疫反应如此之大,我们发现即使是非传染性CMV疫苗也会引起巨大的反应,这一发现进一步加深了这个谜团。该项目的目标是准确了解CMV如何激发这种前所未有的反应。使用非感染性疫苗,我们将找到驱动反应的细胞,并确定它们如何与免疫系统相互作用以驱动反应。这些知识将直接用于我们开发基于CMV的癌症疫苗的其他工作。
英文摘要
DESCRIPTION (provided by applicant): Cytomegalovirus (CMV) infection is characterized by enormous effector/memory T cell responses that are maintained at high levels for life- a phenomenon known as memory inflation. We have reported that "inflationary memory" cells are in fact short lived effector cells continuously differentiating from true memory cells generated early during infection. The true memory cells are not readily transferred from the spleen of an infected host to an infected recipient, and we suggest that they reside in a stromal niche. We have also shown that a single cycle CMV which is unable to spread beyond the cells it infects upon first entering the body drives surprisingly robust memory inflation. These two findings define the paradox that we seek to unravel in this project: how can a tiny number of infected cells present antigen to keep the immune system constantly activated without being subject to immune eradication? We first ask whether the information about viral presence is transmitted to T cells through direct or cross presentation of viral antigen. This will be accomplished by generating a virus expressing Kb in order to limit antigen presentation to directly infected cells.
We will next use an iterative process of organ digestion, cell sorting and bioassays to identify the cells that carry the viral genome and the cells that present antigen to T cells. As an alternative approach, we will generate virus which can be used to infect cre mice to limit antigen expression to particular tissues or cell types. Finally, we will characterize the latently infected
cells with respect to their immunological phenotype, their viral gene expression, and their sufficiency for driving memory inflation upon co-adoptive transfer with memory CD8 and CD4 T cells. Understanding the viral program that drives memory inflation will enable us to intelligently
engineer CMV-vectors as vaccines to generate potent immune responses. It will also help us to understand CMV's role in certain chronic diseases, and its putative association with immunosenescence.
PUBLIC HEALTH RELEVANCE: Cytomegalovirus is a ubiquitous human virus that excites an extremely large immune response from the infected host. This enormous immune response can be harmful, contributing to immunosenescence in the elderly, or helpful, when CMV is used as a vaccine vector. It is not known why the immune response is so large, and the mystery was heightened by our discovery that even a non-infectious CMV vaccine drives an enormous response. The goal of this project is to understand exactly how CMV excites this unprecedented response. Using the non-infectious vaccine, we will find the cells that drive the response and determine how they interact with the immune system to drive the response. This knowledge will be exploited directly in our other work to develop a CMV-based cancer vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell response to fibroblast-trophic CMV vaccine in humans
-
批准号:8973535
-
项目类别:
-
资助金额:$19.23万
-
财政年份:2014
-
负责人:Ann B Hill
-
依托单位:
T cell response to fibroblast-trophic CMV vaccine in humans
-
批准号:8839088
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2014
-
负责人:Ann B Hill
-
依托单位:
Cytomegalovirus and diseases of aging: a secondary analysis of NHANES III data
-
批准号:8247692
-
项目类别:
-
资助金额:$6.31万
-
财政年份:2011
-
负责人:Ann B Hill
-
依托单位:
Cytomegalovirus and diseases of aging: a secondary analysis of NHANES III data
-
批准号:8095593
-
项目类别:
-
资助金额:$6.31万
-
财政年份:2011
-
负责人:Ann B Hill
-
依托单位:
Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine
-
批准号:7796744
-
项目类别:
-
资助金额:$16.78万
-
财政年份:2009
-
负责人:Ann B Hill
-
依托单位:
Inflammation and T Lymphocyte Immunoregulation
-
批准号:8268409
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2009
-
负责人:Ann B Hill
-
依托单位:
Inflammation and T Lymphocyte Immunoregulation
-
批准号:8460120
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2009
-
负责人:Ann B Hill
-
依托单位:
Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine
-
批准号:7742485
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2009
-
负责人:Ann B Hill
-
依托单位:
CD8 T Cell Response to Murine Cytomegalovirus
-
批准号:8698704
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
The CD8 T cell response to murine cytomegalovirus
-
批准号:7540954
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION
-
批准号:7027644
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
The CD8 T cell response to murine cytomegalovirus
-
批准号:7738501
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION
-
批准号:6647699
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
The CD8 T cell response to murine cytomegalovirus
-
批准号:7327774
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION
-
批准号:6879039
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION
-
批准号:6547097
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION
-
批准号:6725479
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION
-
批准号:6706954
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION
-
批准号:6859360
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION
-
批准号:6436965
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2002
-
负责人:Ann B Hill
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: